Literature DB >> 21424425

[The patient after radical prostatectomy: complexity and efficiency of a urological rehabilitation program].

D-H Zermann1.   

Abstract

Timely physical and mental convalescence and an early recovery of functional side effects belong to an efficient treatment concept for prostate cancer. Every prostate cancer patient has a right to take part in a urological rehabilitation program (Germany). The objectives are continence, potency, overcoming physical complaints, reduction of health risk factors, and psychological support. The results presented show the complexity and efficiency of a urological rehabilitation program.

Entities:  

Mesh:

Year:  2011        PMID: 21424425     DOI: 10.1007/s00120-010-2481-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  14 in total

1.  Pelvic floor rehabilitation for continence recovery after radical prostatectomy: role of a personal training re-educational program.

Authors:  Debora Marchiori; Alessandro Bertaccini; Fabio Manferrari; Claudio Ferri; Giuseppe Martorana
Journal:  Anticancer Res       Date:  2010-02       Impact factor: 2.480

Review 2.  Rehabilitation therapy and urinary incontinence after radical retropubic prostatectomy. A critical review of the literature.

Authors:  Domenico Viola; Francesco Comerci; Giuseppe Martorana
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

3.  Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy.

Authors:  A E Kyrdalen; A A Dahl; E Hernes; M Cvancarova; S D Fosså
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-01-26       Impact factor: 5.554

Review 4.  [Corpus cavernosum rehabilitation after radical urooncological procedures].

Authors:  D-H Zermann
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

Review 5.  Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress.

Authors:  Andrew G Matthew; Adam Goldman; John Trachtenberg; John Robinson; Sheri Horsburgh; Kristen Currie; Paul Ritvo
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

6.  Feasibility of an exercise rehabilitation programme for cancer patients.

Authors:  C Stevinson; K R Fox
Journal:  Eur J Cancer Care (Engl)       Date:  2006-09       Impact factor: 2.520

7.  Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial.

Authors:  M Van Kampen; W De Weerdt; H Van Poppel; D De Ridder; H Feys; L Baert
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

8.  Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation.

Authors:  Anja Mehnert; Claudia Lehmann; Thomas Schulte; Uwe Koch
Journal:  Onkologie       Date:  2007-10-16

9.  Health related quality of life significance of single pad urinary incontinence following radical prostatectomy.

Authors:  Matthew R Cooperberg; Viraj A Master; Peter R Carroll
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

Review 10.  Management of erectile dysfunction after radical prostatectomy in 2007.

Authors:  Alberto Briganti; Andrea Salonia; Andrea Gallina; Felix K-H Chun; Pierre I Karakiewicz; Markus Graefen; Hartwig Huland; Patrizio Rigatti; Francesco Montorsi
Journal:  World J Urol       Date:  2007-03-06       Impact factor: 4.226

View more
  3 in total

Review 1.  [Social medical/public health assessment of the ability to work regarding urological and urooncological diseases].

Authors:  D-H Zermann; W Hoffmann; W Vahlensieck
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

2.  [Not Available].

Authors:  D-H Zermann; W Hoffmann; U Otto
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

3.  [Specialist uro-oncological rehabilitation after treatment for prostate cancer--update 2015. Position statement of the working group on "rehabilitation of urological and nephrological diseases" of the German Society of Urology with respect to current S3 guidelines].

Authors:  G Müller; U Otto; W Vahlensieck; D-H Zermann
Journal:  Urologe A       Date:  2015-08       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.